| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Crystal-storing histiocytosis: An unusual relapsing inflammatory CNS disorder
|
Costanzi, Chiara
|
|
2012
|
1 |
2 |
p. 95-99
5 p.
|
article
|
| 2 |
Editors' welcome
|
Banwell, Brenda
|
|
2012
|
1 |
2 |
p. 55-
1 p.
|
article
|
| 3 |
Emerging disease modifying treatments—A therapeutics update from ECTRIMS/ACTRIMS, Amsterdam, 2011
|
Giovannoni, Gavin
|
|
2012
|
1 |
2 |
p. 56-58
3 p.
|
article
|
| 4 |
Epstein–Barr virus in the multiple sclerosis brain – An evasive culprit
|
Pender, Michael P.
|
|
2012
|
1 |
2 |
p. 61-63
3 p.
|
article
|
| 5 |
Moyamoya: Another multiple sclerosis mimic
|
Zaheer, Fariha
|
|
2012
|
1 |
2 |
p. 100-103
4 p.
|
article
|
| 6 |
Multiple sclerosis and risk behavior
|
Hawkes, Christopher H.
|
|
2012
|
1 |
2 |
p. 59-60
2 p.
|
article
|
| 7 |
Patient-rated ease of use and functional reliability of an electronic autoinjector for self-injection of subcutaneous interferon beta-1a for relapsing multiple sclerosis
|
Singer, B.
|
|
2012
|
1 |
2 |
p. 87-94
8 p.
|
article
|
| 8 |
The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis
|
Baker, David
|
|
2012
|
1 |
2 |
p. 64-75
12 p.
|
article
|
| 9 |
The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristics
|
Lindsey, J.W.
|
|
2012
|
1 |
2 |
p. 81-86
6 p.
|
article
|
| 10 |
Urine: An under-studied source of biomarkers in multiple sclerosis?
|
Dobson, Ruth
|
|
2012
|
1 |
2 |
p. 76-80
5 p.
|
article
|
Journal description